Evaluation of the Protective Effect of the Secondary Root’s Extract and Partitions of Devil’s Claw (Harpagophytum procombens) on Ulcerative Colitis Caused by Acetic Acid in Rats Authors: Maryam Salehi, Afsaneh Yekdaneh, Maryam Derakhshan, Mohsen Minaiyan Published: 2026 ABSTRACT Background:Ulcerative colitis is an autoimmune disease with an unfamiliar etiology, which caused by environmental, microbial, and genetic factors. Harpagophytum procumbens (H. procumbens, Devil’s Claw), could be effective in the treatment of colitis due to its strong anti-inflammatory, antioxidant and restorative effects. Therefore, this research aimed to explore this property.Methods:The hydroalcoholic extract of H. procumbens was prepared and partitioned into aqueous and ethyl acetate parts. Total phenols of extract and partitions were determined and three increasing doses of them (50, 100, and 200 mg/kg), dexamethasone (1 mg/kg), mesalazine (100 mg/kg) and normal saline (5 mL/kg) were examined in male Wistar rats as test, reference and control groups respectively. Colitis induction was conducted via rectal instillation of acetic acid and the treatments continued for five consecutive days. Finally, the colon tissues were evaluated for colitis biomarkers.Results:Total phenols were equivalent to 5.19 ± 0.09, 2.12 ± 0.03 and 7.71 ± 0.01 gallic acid equivalent (mg)/g of dry extract, aqueous and ethyl acetate partitions, respectively. Greater doses of hydroalcoholic extract and aqueous (200 mg/kg) and ethyl acetate partition (50, 100 and 200 mg/kg) improved the ulcerative colitis in terms of colon weight, ulcer index and total colitis index in significant manner. Similar results obtained after myeloperoxidase (MPO) measurements however, for malondialdehyde (MDA) value, most doses of the extract and partitions were effective.Conclusions:H. procumbens hydroalcoholic extract and its partitions ameliorated experimental colitis probably in a dose-related manner. It seems antioxidant, anti-inflammatory and anti-ulcerative effects especially due to non-polar ingredients, are responsible. Introduction Inflammatory bowel disease (IBD) is an autoimmune and chronic inflammatory disease of the gastrointestinal tract that has alternating periods of relapse and recovery, and its two main subtypes include Crohn’s disease and ulcerative colitis.[1] IBD can occur at any age however, its occurrence is more common in young and adolescence, so that 25% of cases are diagnosed before the age of 20.[2] Although the etiology of IBD has not exactly known, the pathogenesis of this disease is very complex and a combination of factors such as genetic, immunological, environmental, oxidative stress, microbial, intestinal mucosal barrier inefficiency and unhealthy life style can be effective in IBD.[34] Molecular factors such as nuclear factor (NF)-κB, nitric oxide (NO), cyclooxygenase-2 (Cox-2), and leukotriene B4 (LB4) are also involved in the pathogenesis of this disease.[15] Treatment of ulcerative colitis is done according to the severity of the disease; therefore, the first line of treatment for mild to moderate degrees of the disease is 5-aminosalicylates, while in cases of recurrence, corticosteroids and moderate to severe degrees of immunosuppressant drugs (azathioprine or 6-mercaptopurine) and biological drugs are applied. Anti-TNF-alpha drugs (adalimumab, infliximab, etc.) are using as maintenance treatment in moderate to severe cases of the disease and reduce the need for aggressive interventions such as surgery.[46] Current treatments are associated with various side effects including allergic reactions, bone marrow suppression, osteoporosis, liver damage, pancreatitis, pulmonary fibrosis, and adrenal disease.[56] These side effects have given a special attention to the complementary and alternative medicine, especially the use of medicinal plants. It has reported that medicinal plants can treat IBD with different mechanisms, including inhibition of pro-inflammatory and inflammatory cytokines, reactive oxygen species (ROS), oxydoradicals, immune system regulation, and antiplatelet activity, though no specific and serious complications have been reported so far.[78] Harpagophytum is a tuberous plant from the Sesame family (Pedaliaceae) native to the Kalahari Desert and Namibian steppes, which is also known as the Devil’s claw because of its hooked fruits. This genus includes two species; H. procombens and H. zeyheri.[9] H. procumbens is more effective than H. zeyheri due to having more compounds that are active with therapeutic uses. H. procombens is a medicinal plant native to South Africa and has received attention due to its many therapeutic effects.[10] Due to the inflammatory nature of colitis, the Devil’s claw plant can play a role in the treatment of colitis due to its anti-inflammatory properties, and it has not been studied in this regard so far.[11] The likely reason for the therapeutic use of this plant is the significant percentage of iridoid glycosides in the secondary roots.[12] Iridoid glycosides, including harpagoside, harpagid and procumbide, make up the majority of secondary root compounds of Devil’s claw. Other active compounds found in the plant include phenolic glycosides, phenolic acids (caffeic, cinnamic and chlorogenic acids), phytosterols (β-sitosterol), carbohydrates (monosaccharides and polysaccharides), flavonoids (luteolin and kaempferol) and triterpenes (urosolic and oleanolic acids). The plant’s root also contains small amounts of volatile oils.[13] Due to the strong anti-inflammatory and analgesic effects of H. procumbens, this medicinal plant made in different formulations to treat a wide range of diseases including osteoarthritis, rheumatoid arthritis, and chronic neuropathic pain.[131415] Additionally, due to its antimicrobial and antioxidant effects, this plant consumed in other diseases such as, indigestion or gastrointestinal diseases, Alzheimer’s, syphilis, diabetes, and urinary infections.[121314151617] In local application, the dried and powdered root of the plant used as a dressing or wound healing ointment.[13] Considering the existence of effective compounds with effects and considering the inflammatory and ulcerative nature of ulcerative colitis, the purpose of the present research was to investigate the preventive and/or therapeutic effects of the total (hydroalcoholic) extract, aqueous and ethyl acetate partitions of Devil’s claw root in an animal model of ulcerative colitis. Methods Drugs and chemicals Dexamethasone and mesalazine powders were generously provided by Iran Hormone Company, Tehran, Iran. Hexadecyl trimethyl ammonium bromide (HTAB) and O-dianizidine dihydrochloride (ODZ) were provided by Sigma Company, Darmstadt, Germany. Folin-Ciochalteu reagent, diethyl ether oxide, ethyl and methyl alcohols, n-hexane, glacial acetic acid, and formaldehyde were supplied by Merck Company, Darmstadt, Germany. The hydroalcoholic extract powder of this plant was purchased from Rahman-Gostaran Pharmaceutical Company, Ghazvin, Iran. Animals Seventy-eight male Wistar rats with a weight range of 180–220 g bred in the animal cage of the School of Pharmacy, Isfahan University of Medical Sciences, were used. They were kept under the same and standard conditions in terms of light (12.12 hours), humidity (50–60 percent), temperature (21–23°C) and rodent’s nutrition. During the experiment, the rats had easy access to tap water and food except 24 hours, before the induction of colitis, when they should be in fasting state and water consumption was completely free during this time interval. The whole process of intervention on animals was approved according to the instructions of the Ethical Committee of Isfahan University of Medical Sciences. The national code of ethics for this research is IR.MUI.AEC.1402.026. Preparation of herbal extracts Twenty grams (g) of Devils clove root’s hydroalcoholic extract as dry powder was purchased from Rahman Gostaran Company, Qazvin and was dissolved in ethyl acetate (75 mL) and the same volume of water and decanted. The ethyl acetate layer was placed on top and decanted. For complete extraction, this process was repeated three times and the ethyl acetate layers were added to each other. The remaining aqueous layer (after three extractions with ethyl acetate) was also dried and used as the aqueous partition for in vivoexperiments. The resulting partitions were concentrated using a rotary evaporator at 35°C and dried in a freeze dryer.[18] Determining the amount of dry matter in the extract To determine the amount of dry matter in the extract, we took 0.5 g of the hydroalcoholic, aqueous and ethyl acetate extracts as dry powders and put it in the oven at 100°C for 1 hour. After cooling, they were weighed and heated again for 15 min. This process was repeated for three times and finally the amount of dry extract was determined for extracts or partitions.[19] Determining of total phenol content of plant extracts The total phenolic content of the root of Devil’s claw was measured using Folin-Ciochalteu method.[20] In this method, gallic acid is used as a standard, and the basis of the work is the reduction of Folin-Ciochalteu reagent by phenolic compounds in an alkaline environment and the creation of a blue complex, whose absorption is read at 765 nm. Finally, the standard curve was drawn based on the gallic acid concentration and the total phenolic content was calculated as gallic acid equivalent (GAE, mg) using the line equation obtained from the curve. Grouping design The groupings were as follows: Group 1 (Normal): Normal rats were treated with vehicle (5 mL/kg, normal saline/tween 20, 0.1%) by oral route (p.o.). Group 2 (Colitis Control): Colitis rats were treated with vehicle (5 mL/kg, normal saline/tween 20, 0.1%) (p.o.). Groups 3, 4, and 5: Colitis rats were treated with H. procumbens hydroalcoholic extract (HPHE) at doses of 50, 100, and 200 mg, p.o. Groups 6, 7, and 8: Colitis rats were treated with H. procumbens aqueous partition (HPAP) at doses of 50, 100, and 200 mg, p.o. Groups 9, 10, and 11: Colitis rats were treated with H. procumbens ethyl acetate partition (HPEAP) at doses of 50, 100, and 200 mg, p.o.[1521] Group 12 (reference): Colitis rats were treated with dexamethasone (1 mg/kg, i.p.). Group 13 (reference): Colitis rats were treated with mesalazine (100 mg/kg, p.o.).[19] Induction of colitis Before the experiment, the rats of each group were kept in the laboratory animal room for one week to adapt with the laboratory environment. Experimental colitis was developed by a method previously performed in our laboratory.[22] In this way, the rats were anesthetized by isoflurane (5%), and through a suitable tube with 8 cm in length and 2 mm in diameter, inserted 2 mL of 3% acetic acid into the colon and kept the animal upside down for 30 sec. All the treatments were conducted p.o., using a feeding tube 2 hour before and every 24 hours after the induction of colitis and continue until the fifth day. Macroscopic assessment of colon damage One the day after the last dose of extracts/drugs, the animals in each group were sacrificed in CO2 saturated box. Their colons were removed and washed by normal saline (0.9%) solution and after weighing, they were spread and some digital and colorful photos were taken. Then the surface of ulcer was measured by Fiji P (Image Analysis Program) in square centimeters. The severity of tissue damage was determined using the numbers 0 (no ulcer), 1 (inflammation, edema, thickening and superficial ulcer), 2 (bleeding and deep ulcer) and 3 (necrosis and/or perforation).[22] The tissues were then cut into three equal parts with a longitudinal section and one part were kept in 10% buffered formalin to prepare microscopic sections and stained with hematoxylin and eosin (H/E). The other parts of the tissues were placed in separate tubes that were coded and transferred to a -70°C freezer to be used to evaluate the activity of myeloperoxidase (MPO) and malondialdehyde (MDA) enzymes, respectively.[23] Assessment of histopathologic parameters Tissue samples were placed in paraffin for histopathological assessment, then processed and sliced into 4-µm diameter layers. The samples were then deparaffinized using xylene and hydrated with ethyl alcohol. Subsequently, hematoxylin and eosin (H and E) staining was performed. Inflammation severity (0: none, 1: slight, 2: moderate, 3: severe) and its extent (0: none, 1: mucosal, 2: mucosal and sub-mucosal, 3: transmural embracement), crypt damage (0: none, 1: basal 1/3 damaged, 2: basal 2/3 damaged, 3: surface epithelium intact only, 4: crypt and surface epithelium distorted), and leukocyte infiltration (0: trace, 1: mild, 2: moderated, 3: severe) were assessed. The total colitis index (0–13) was calculated by summing the variables. Histopathological parameter evaluation was carried out using a Zeiss microscope fitted with a color video camera (Sony, Japan) for digital imaging.[24] Assessment of MPO activity The colon tissue (0.1 g) was completely crushed with a scalpel blade. Then the sample entered the homogenizer and phosphate buffer containing 0.5% (HTAB) was poured up to the mark line (5 mL) and homogenized for three cycles of 45 sec. The resulting mixture was sonicated for 15 sec and finally, it was centrifuged for 15 min at 4000 rpm. A volume of 0.1 mL from the supernatant was combined with 2.9 mL of phosphate buffer that included 0.005% hydrogen peroxide and 0.167 mg/ml ODZ and its absorption at 450 wavelength was determined at 0 and 3 min and the difference between these two readings were reported as a measure of MPO enzyme activity in units per 100 mg of tissue.[25] Assessment of MDA To each tissue of colon (0.1 g), 1 mL potassium chloride (1.15% v/100 mg tissue) was added and homogenized. After centrifugation of samples for 10 min at 1200 rpm, the supernatant was measured for the content of MDA using an MDA assay kit (Navand-Salamat, Urmia). The samples were then centrifuged for 15 min at 3000 rpm, and the absorbance at 550 nm was determined.[19] Statistical analysis The data were analyzed to obtain the mean and standard error of the mean (SEM). Nonparametric data were expressed as median (range of variation). One-way ANOVA analysis was conducted on parametric data, while the Mann-Whitney U test was applied to non-parametric data. Changes in rat weight were statistically examined using the student’s paired t-test. The statistical analyses were executed utilizing GraphPad Prism eight software. Results The weight of aqueous and ethyl acetate partitions, obtained after partitioning, were 16.7 grams and 2.9 grams respectively. These extracts were later used to conduct pharmacological studies. Amount of dry matter in the extracts The average percentage of dry matter after three repetitions for concentrated hydroalcoholic extract (HPHE), aqueous (HPAP), and ethyl acetate partitions (HPEAP) were obtained as 99.8%, 97.1% and 99.7%, respectively. Total phenol contents of plant’s extracts The number of polyphenols in HPHE, HPAP and HPEAP samples were equivalent to 5.19 ± 0.09, 2.12 ± 0.03 and 7.71 ± 0.01 gallic acid equivalent (mg) gof dry extracts, respectively. The effect of extracts on animal’s weight The results of administering different doses of HPHE, HPAP, HPEAP and reference drugs on the weight changes of rats showed that the normal group exhibited increased weight significantly (P < 0.05) [Table 1]. On the other hand, the weight of the control group decreased significantly (P < 0.001), which indicates disease induction. Administration of different doses of the extracts inhibited the weight loss process, but significant weight gain happened in HPEAP group (100 and 200 mg/kg) (P < 0.05). Administration of dexamethasone was accompanied with significant weight loss (P < 0.05) however, mesalazine administration did not show significant weight change (P < 0.05) [Table 1]. Table 1The effect of different doses of H. procumbens extracts on the weight changes of ratsGroups/doses (mg/kg)BeforeAfter% Changes P Normal176.8±6.9185.7±12.05.0*Control colitis185.8±8.1165.7±6.5−10.8***HPHE50170.3±4.9172.0±5.30.9NSHPHE100174.5±5.5171.5±4.5−1.7NSHPHE200180.5±5.8178.2±4.8−1.2NSHPAP50179.3±7.3178.7±2.3−0.3NSHPAP100176.8±4.9177.0±3.20.1NSHPAP200181.0±9.1177.7±3.7−1.8NSHPEAP50177.8±6.3178.8±3.50.5NSHPEAP100171.2±6.3177.2±3.73.5*HPEAP200173.7±1.7179.3±2.63.2*Dexamethasone1177.8±6.8168.0±5.0−5.5*Mesalazine100177.7±4.9174.7±5.6−1.6NSData are presented as Mean±SD (n=6). *P<0.05, **P<0.01, ***P<0.001 indicate significant difference versus control colitis. Statistical analysis of this parameter was performed using Student’s t paired test. Normal: treated with the extract vehicle without colitis, Control colitis: treated with the extract vehicle after colitis induction, HPHE: H. procumbens hydroalcoholic extract, HPAP: H. procumbens aqueous partition, HPEAP: H. procumbens ethyl acetate partition, NS: non-significant The effect of different doses of H. procumbens extracts on the weight changes of rats Data are presented as Mean±SD (n=6). *P<0.05, **P<0.01, ***P<0.001 indicate significant difference versus control colitis. Statistical analysis of this parameter was performed using Student’s t paired test. Normal: treated with the extract vehicle without colitis, Control colitis: treated with the extract vehicle after colitis induction, HPHE: H. procumbens hydroalcoholic extract, HPAP: H. procumbens aqueous partition, HPEAP: H. procumbens ethyl acetate partition, NS: non-significant The effect of plant’s extracts on macroscopic parameters HPHE and HPAP at the dose of 200 mg/kg and HPEAP at all three doses (50, 100 and 200 mg/kg) caused a significant decrease in colon weight and ulcer index compared to the control group [Table 2, Figure 1]. Regarding ulcer area and ulcer severity, HPHE and HPAE at doses of 100 and 200 mg/kg and HPEAP at all three doses were able to significantly reduce them compared to the control group. Both reference drugs reduced colon weight and ulcer indices as expected (P < 0.001) [Table 2, Figure 1]. Table 2The effect of different doses of H. procumbens extracts on the macroscopic parameters of colitisGroup/dose (mg/kg)Ulcer score (0–3)Ulcer area (cm2)Ulcer index (0–10)Weight of colon (g/8 cm)Normal0.0 (0–0)0.0±0.00.0±0.00.51±0.02Control colitis2.75 (2–3)###4.44±0.33###7.11±0.33###1.48±0.06###HPHE502.0 (0–3)3.43±0.535.43±1.091.13±0.05HPHE1001.5 (0–2.5)2.65±0.49*4.15±0.621.19±0.11HPHE2001.0 (0–2)*1.67±0.45**2.67±0.69***0.72±0.09***HPAP502.0 (1–3)4.43±0.626.43±0.751.21±0.05HPAP1001.5 (0–3)*2.9±0.14*4.28±0.381.11±0.06HPAP2001.0 (0–2)**1.62±0.30***2.46±0.57***0.94±0.02**HPEAP501.0 (0–2)**1.83±0.31***2.91±0.30***0.97±0.05*HPEAP1001.0 (0–2)**1.44±0.18***2.19±0.32***0.78±0.1***HPEAP2000.5 (0–2)**1.50±0.20***2.17±0.37***0.76±0.07***Dexamethasone10.5 (0–1)***0.66±0.20***1.16±0.36***0.69±0.02***Mesalazine1000.5 (0–2)**0.89±0.20***1.47±0.26***0.75±0.02***Data are presented as Mean±SEM (n=6). *P<0.05, **P<0.01, ***P<0.001 indicate significant difference versus control colitis. ###indicate significant difference versus normal group. Normal: treated with the extract vehicle without colitis, Control colitis: treated with the extract vehicle after colitis induction, HPHE: H. procumbens hydroalcoholic extract, HPAP: H. procumbens aqueous partition, HPEAP: H. procumbens ethyl acetate partition The effect of different doses of H. procumbens extracts on the macroscopic parameters of colitis Data are presented as Mean±SEM (n=6). *P<0.05, **P<0.01, ***P<0.001 indicate significant difference versus control colitis. ###indicate significant difference versus normal group. Normal: treated with the extract vehicle without colitis, Control colitis: treated with the extract vehicle after colitis induction, HPHE: H. procumbens hydroalcoholic extract, HPAP: H. procumbens aqueous partition, HPEAP: H. procumbens ethyl acetate partition Macroscopic images of colon tissue after induction of colitis by acetic acid in rats (a) The extract vehicle without colitis induction (normal) (b) The extract vehicle after colitis induction (control colitis) (c) The HPHE (H. procumbens hydroalcoholic extract) at a dose of (50 mg/kg) after colitis induction (d) The HPHE at a dose of (200 mg/kg) after colitis induction (e) the HPAP (H. procumbens aqueous partition) at a dose of (50 mg/kg) after colitis induction (f) The HPAP at a dose of (200 mg/kg) after colitis induction (g) The HPEAP (H. procumbens ethyl acetate partition) at a dose of (200 mg/kg) after colitis induction (h) dexamethasone at a dose of (1 mg/kg) after colitis induction (i) mesalazine at a dose of (100 mg/kg) after colitis induction The effects of plant extracts on pathologic features of colitis HPHE and HPAP at the grater dose of 200 mg/kg and HPEAP at all three doses (50, 100 and 200 mg/kg) significantly (at least P < 0.05) reduced histopathological symptoms and total colitis index as microscopic assessment factor of colitis compared to the control group (P < 0.05). Dexamethasone and mesalazine as reference agents improved all aspects of colitis features in microscopic samples (P < 0.001) [Table 3, Figure 2]. Table 3The effect of different doses of H. procumbens extracts on the microscopic parameters of colitisGroup/dose (mg/kg)Inflammation Severity (0–3)Inflammation Extent (0–3)Leukocyte infiltration (0–3)Crypt Damage (0–4)Total Colitis index (0–13)Normal0.0 (0–0)0.0 (0–0)0.0 (0–0)0.0 (0–0)0.0 (0–0)Control colitis3.0 (3–3)###3.0 (3–3)###3.0 (2–3)###4.0 (3–4)###13.0 (11–13)###HPHE502.5 (2–3)3.0 (2–3)3.0 (2–3)4.0 (3–4)12.5 (9–13)HPHE1002.5 (2–3)2.5 (1–3)3.0 (2–3)3.0 (3–4)11.0 (8–13)HPHE2001.5 (0–2)**2.0 (1–2)**1.5 (0–2)*2.0 (1–3)**7.0 (2–9)**HPAP503.0 (2–3)3.0 (3–3)3.0 (2–3)4.0 (3–4)13.0 (10–13)HPAP1003.0 (2–3)2.5 (2–3)3.0 (2–3)3.0 (3–4)11.5 (8–13)HPAP2001.5 (1–3)*2.0 (1–3)*3.0 (1–3)2.0 (2–3)**8.5 (5–12)**HPEAP502.0 (1–2)**2.5 (1–3)*2.0 (1–2)*2.5 (1–3)*9.0 (4–10)**HPEAP1001.0 (0–1)**1.0 (0–1)**2.0 (0–2)*1.0 (0–1)**5.0 (0–5)**HPEAP2001.0 (0–1)**1.0 (0–1)**2.0 (0–2)*0.0 (0–1)***4.0 (0–5)**Dexamethasone11.0 (0–1)**0.5 (0–1) **1.0 (0–1)**0.0 (0–0)***2.5 (0–3)***Mesalazine1000.5 (0–1)**0.5 (0–1) **1.0 (0–1)**1.0 (0–2)**3.0 (0–5)**Data are presented as Median (range) (n=6). *P<0.05, **P<0.01, and ***P<0.001 indicate significant difference versus control colitis. ### indicate significant difference versus normal group. Normal: treated with the extract vehicle without colitis, Control colitis: treated with the extract vehicle after colitis induction, HPHE: H. procumbens hydroalcoholic extract, HPAP: H. procumbens aqueous partition, HPEAP: H. procumbens ethyl acetate partition The effect of different doses of H. procumbens extracts on the microscopic parameters of colitis Data are presented as Median (range) (n=6). *P<0.05, **P<0.01, and ***P<0.001 indicate significant difference versus control colitis. ### indicate significant difference versus normal group. Normal: treated with the extract vehicle without colitis, Control colitis: treated with the extract vehicle after colitis induction, HPHE: H. procumbens hydroalcoholic extract, HPAP: H. procumbens aqueous partition, HPEAP: H. procumbens ethyl acetate partition Microscopic images of colon tissue after induction of colitis by acetic acid in rats. (a) The extract vehicle without colitis induction (normal), blow arrows represents normal mucosa and sub-mucosal layers and crypts (b) The extract vehicle after colitis induction (control colitis), red arrows represents mucosal damage, sub-mucosal and crypt degeneration plus leucocyte accumulation (c) The HPHE (H. procumbens hydroalcoholic extract) at a dose of (50 mg/kg) after colitis induction (d) The HPHE at a dose of (200 mg/kg) after colitis induction (e) the HPAP (H. procumbens aqueous partition) at a dose of (50 mg/kg) after colitis induction (f) The HPAP at a dose of (200 mg/kg) after colitis induction (g) The HPEAP (H. procumbens ethyl acetate partition) at a dose of (200 mg/kg) after colitis induction (h) dexamethasone at a dose of (1 mg/kg) after colitis induction (i) mesalazine at a dose of (100 mg/kg) after colitis induction The effect of extracts on biochemical parameters MPO activity HPHE and HPAP at the dose of 200 mg/kg could reduce the level of MPO activity by a significant degree compared to the control group (P < 0.01). However, HPEAP with all three doses could significantly reduce MPO activity compared to the control group (at least P < 0.05). In the groups received dexamethasone and mesalazine as reference remedies, the activity of MPO showed a significant dip compared to the control group (P < 0.001) [Supplementary Figure 1]. MDA value HPHE and HPAP with doses of 100 and 200 mg/kg were able to significantly reduce MDA levels compared to the control group (at least P < 0.05). However, HPEAP with all three doses could significantly reduce MDA levels comparison to the control group (at least P < 0.01). In the groups received dexamethasone and mesalazine as reference remedies, the MDA level showed a significant decrease compared to the control group [Supplementary Figure 2]. Discussion Ulcerative colitis is one of the treatment challenges in the global health system. The side effects of conventional drugs, the insufficient effectiveness of these treatments, and the need for long-term use of them highlight the need for more attention to complementary therapies, especially the use of medicinal plants.[26] In the current research, the macroscopic, microscopic, and biochemical parameters of colitis were investigated to evaluate the protective and therapeutic function of hydroalcoholic extract, aqueous and ethyl acetate fractions of the secondary root of Devil’s Claw on rats with acetic acid-induced colitis. Intra-rectal induction of colitis using acetic acid is one of the most common animal models for studying IBD and is scientifically accepted, given the similarity of the metabolic pathways of arachidonic acid and the inflammatory mediators produced to the acute phase of colitis in humans.[27] The results obtained, including the weight loss of the animals over a 5-day period, increased colon weight associated with bleeding, edema, and tissue necrosis, the increase in MPO and MDA levels, indicate the effective induction of laboratory colitis by the aforementioned method. Regarding the changes in the weight of the rats with induced colitis, in the groups treated with the extracts at most doses, the weight loss process was slowed or stopped even though in the treatment groups with ethyl acetate partition (100 and 200 mg/kg), a significant weight gain was happened. This clinical result clearly showed that the extracts of H. procumbens were effective in preventing the progression of colitis. The exception to this was in the case treated with dexamethasone, which, despite the obvious therapeutic effect, was accompanied by a meaningful decrease in body weight, probably due to its catabolic effects.[28] The weight of 8 cm of isolated colon tissue is an indicator to evaluate the severity of inflammation and colitis and the level of immune system response.[29] Moreover the increase in colon weight indicates the accumulation of interstitial water, increased capillary permeability, cell infiltration, and is also an important criterion for diagnosing edema.[27] A significant decrease in colon weight, ulcer area, severity and index was occurred in groups treated with HPHE and HPAP at the highest dose (200 mg/kg) while HPEAP at all three doses (50, 100, and 200 mg/kg) were effective. The effects of the treatment groups were also examined by pathological studies to confirm the macroscopic results and clearly demonstrate the inflammatory changes in the colon. In general, the pathological results were consistent with the results observed in the macroscopic observations. Iridoid glycosides in Devil’s Claw have anti-inflammatory and analgesic properties. Harpagoside, the first and most important identified iridoid glycoside, is considered as the reference standard for comparing the effects of these compounds.[12] According to the similar studies, the analgesic and anti-inflammatory effects of the secondary root extract of the Devil’s claw plant are related to bioactive compounds such as harpagid, harpagoside, 8-p-coumaroyl harpagid and acteoside, which could be extracted by ethyl acetate solvent.[123031] A Cochrane review conducted by Gagnier et al. (2007),[32] revealed that administering daily dosages of H. procumbens, combined with either 50 mg or 100 mg harpagoside, resulted in reduced pain for the subjects with low back pain. Additional studies also demonstrated that lower doses of H. procumbens functioned within a smaller trial population. Findings of an in vitro investigation carried out by Mncwangi et al. (2012),[10] revealed that extracts from the root tubers of H. procumbens suppressed rheumatoid arthritis and osteoarthritis inflammation by inhibiting the production of pro-inflammatory mediators like interleukin-induced metalloproteinases. MPO is a peroxidase enzyme and known as one of the most abundant proteins found in neutrophil granules. This enzyme releases into the extracellular space during the degranulation of neutrophils and plays a role by producing reactive oxygen species. Also, MPO is used as a valuable marker to evaluate the level of leukocyte penetration into the tissue and is frequently used as a strong marker of colon inflammation in similar investigations.[3334] According to the obtained results, HPHE and HPAP with a dose of 200 mg/kg and HPEAP with all test doses were able to cause a significant decrease in MPO compared to the control group. Doses of 50 and 100 mg/kg of HPHE and HPAP could not cause a significant difference in MPO levels compared to the control group, and this could partially explain the lack of effectiveness of this dose of extracts on microscopic and macroscopic parameters of the colon. It is worth noting that phenolic glycosides in the roots of Devil’s claw also have anti-inflammatory effects; the most important phenolic glycoside of this plant is verbascoside (acteoside), which has anti-inflammatory effects equal to or even greater than harpagoside.[35] Other phenolic glycosides of Devil’s claw have strong antioxidant and antimicrobial activities.[36] The results of a study conducted by Weckesser et al. (2007),[37] demonstrated that Devil’s claw extract is effective in inhibiting the growth of anaerobic bacteria and only two strains of aerobic bacteria. But the interesting result was that this inhibition effect is not due to the presence of harpagoside, which is the most important compound of this plant. Given that the role of the intestinal microbiota in the pathology and severity of colitis has received special attention and emphasis, it can be expected that the antimicrobial effects of devil’s claw play at least a role in the occurrence of these beneficial effects.[38] Minor chemical compounds of Devil’s claw, such as flavonoids and phenolic or aromatic acids, terpenoids, ursolic acid, oleanolic acid, and beta-sitosterol, also have anti-inflammatory effects.[12] Malondialdehyde on the other hand, is an active aldehyde compound that is produced by the peroxidation of unsaturated fatty acids. Its measurement in biological samples helps to assess the level of lipid peroxidation and cell damage in plants and animals and used as a marker for oxidative stress in cells and tissues. In this study, doses of 100 and 200 mg/kg of HPHE and HPAP and HPEAP at all doses were able to significantly reduce MDA levels compared to the control group. Since phytochemical studies found the highest percentage of phenolic compounds in the HPEAP, the better effectiveness of this partition on inflammatory and oxidative stress parameters could be attributed to these compounds. In the same direction methanolic extract of Devil’s claw can prevent oxidative stress or cell death against common oxidizing factors.[11] These results are in accordance with the findings of a study conducted by Erkek et al. (2023)[39] on acetic acid-induced colitis. In the latter study, similarly, a daily dose of 300 mg of devil’s claw extract for 2 weeks significantly reduced the level of MDA in the plasma of rats with colitis. Devil’s claw extract was also able to reduce plasma levels of many inflammatory and pro-inflammatory cytokines (e.g. nitric oxide (NO), interleukin-6 (IL-6) and tumor necrosis factor-α (TNF-α)) and increase antioxidant capacity (e.g. total antioxidant capacity (TAC), superoxide dismutase (SOD)) in the extract groups. However, it is not clear what type of extract and that part of the plant was used in the study of Erkek et al. Furthermore, only one dose of the extract was examined, which limits the possibility of examining the dose-effectiveness relationship. The strengths of our study are the simultaneous examination of the total extract and its derived two partitions of Devil’s Claw roots on colitis and its evaluation from various clinical, macroscopic, pathological, and biochemical aspects. However, due to budget limitations, inflammatory cytokines and antioxidant capacity were not examined in involved tissue. Therefore, in future studies, it seems necessary to measure inflammatory cytokines and antioxidant capacity in colon tissue, while trying this study in another model of experimental colitis (e.g. tri-nitrobenzene sulfonic acid (TNBS)) induction to provide the basis for future clinical and human studies. Conclusions The results obtained from this study indicated that the hydroalcoholic and aqueous extracts of the secondary root of H. procumbens (Devil’s Claw), in higher experimental doses and ethyl acetate extract with all prescribed doses caused recovery of induced colitis. In overall, HPHE and HPEAP had better effects on colitis improvement than HPAP, probably due to the presence of more semipolar and nonpolar compounds including phytosterols, flavonoids, etc., More detailed-investigations are required to establish the anticolitis efficiency of this medicinal plant at clinical setting. Ethics approval All the animal procedures were carried out according to the national guidelines and recommendations represented by the Ethics Committee of Isfahan University of Medical Sciences (IR.MUI.AEC.1402.026). Conflicts of interest There are no conflicts of interest. The effect of different doses of H. procumbens extracts on myeloperoxidase (MPO) enzyme activity in colon tissue. Data are presented as Mean ± SEM (n = 6). *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant difference versus control colitis. ### indicate significant difference versus normal group. HPHE: H. procumbens hydroalcoholic extract HPAP: H. procumbens aqueous partition HPEAP: H. procumbens ethyl acetate partition The effect of different doses of H. procumbens extracts on malondialdehyde (MDA) value in colon tissue. Data are presented as Mean ± SEM (n = 6). *P < 0.05, **P < 0.01, ***P < 0.001 indicate significant difference versus control colitis. ### indicate significant difference versus normal group. HPHE: H. procumbens hydroalcoholic extract HPAP: H. procumbens aqueous partition HPEAP: H. procumbens ethyl acetate partition